PLRX
PLRX
NASDAQ · Pharmaceuticals

Pliant Therapeutics Inc

$1.16
-0.02 (-1.69%)
As of Jun 21, 10:43 PM ET ·
Analyst Consensus
Sell
11
Analysts
Moderate
Coverage
Buy 1 9%
Hold 6 55%
Sell 4 36%
Price Target
Analyst Price Target +1,372.4% upside
Low Target $13.48
Average Target $17.08
High Target $25.30
Current Price $1.16
Current
$1.16
Target
$17.08
$13.48 $17.08 avg $25.30
Scenario Analysis
Bear Case
$13.48
1,062.1%
Low target
Base Case
$17.08
+1,372.4%
Avg target
Bull Case
$25.30
+2,081.0%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$1.95
-40.5% from high
52-Week Low
$1.09
+6.4% from low
Target vs 52W High
$17.08
+775.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%